在异形性中精神病学障碍
Saloua Mrabet1,2, Syrine Belguith1, Imen Kacem1,2
1Department of Neurology, LR 18SP03, Clinical Investigation Centre Neurosciences and Mental Health, Razi University Hospital, Manouba Tunisia.
La Tunisie medicale
|March 12, 2024
概括
精神症状在异形中很常见,影响61%的患者. 女性性别和更长的持续时间增加了风险,而某些药物可以减少抑郁症.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 临床医学 临床医学
背景情况:
- 和精神疾病之间的联系已经得到了充分证实.
- 异形性通常是良性的,但精神病并发症可能会使结果变得更糟.
研究的目的:
- 为了确定患有异常性的患者精神症状的频率.
- 在这个患者群体中确定与精神病症状相关的因素.
主要方法:
- 一项为期一年的前性研究包括连续患有异常性的患者.
- 排除标准:先前的精神科随访或病后的精神疾病.
- 使用验证的尺度 (NDDE,GAD-7,NPI) 评估的精神病症状.
主要成果:
- 在101名异常性患者中,有61%的人观察到精神症状.
- 焦虑 (36.6%),精神病特征 (21%) 和抑郁 (15.8%) 是最常见的.
- 女性性别和更长的持续时间是显著的风险因素;卡巴马西平和瓦尔酸的使用与较低的抑郁率相关.
结论:
- 精神障碍在异形中很常见,焦虑和精神病特征是最常见的.
- 女性的性别和疾病持续时间是精神病症状的关键决定因素.
- 这些因素值得在异常性的临床治疗中加以考虑.
相关概念视频
Seizures: Classification
347
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
347
Arteries of the Lower Limbs
189
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
189
Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
Antiepileptic Drugs: GABAergic Pathway Potentiators
399
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
399
Mania and Antimanic Drugs: Overview
179
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
179
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
631
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
631


